Extraction, purification, structural identification, and anti-senescent activity of novel pearl peptides on human dermal fibroblasts.
Abstract
The purpose of the present study was to prepare novel anti-senescent peptides from pearls, characterize their primary sequence and secondary structure, and investigate their protective effects and molecular mechanisms towards D-galactose (D-gal)-induced senescence on human dermal fibroblasts (HDFs). Novel pearl peptides with a purity of 96.58 % and maximum yield of 3.29 % were obtained using ultrasonic-assisted acetic acid extraction strategy under the optimal extraction conditions (ultrasonic power 200 W, ultrasonic time 70 min, and the ratio of pearl powder to acetic acid 1:20). It is sequenced mainly as five novel anti-senescent peptides with molecular weight < 2000 Da, and consisted of β-sheet (43.2 %), random coil (32.1 %), β-turn (21.2 %) and α-helix (3.5 %) analyzed by LC-MS/MS, FT-IR and CD spectroscopy. Further anti-senescent experiments showed that pearl peptides can increase cell viability, restore DNA damage, and suppress the accumulation of ROS as well as senescence-associated-β-galactosidase (SA-β-gal). The molecular mechanism may be that pearl peptides down-regulate the gene and protein expressions of senescence-associated proteins p53, p21, and p16. Therefore, novel pearl peptides could be developed as functional foods or nutritional supplements for the prevention of skin aging.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper investigates the anti-senescent properties of novel peptides derived from pearls, focusing on their effects on human dermal fibroblasts and the underlying molecular mechanisms. While it addresses a relevant aspect of aging—cellular senescence—it primarily explores a specific intervention rather than a broader understanding of aging mechanisms. The findings contribute to the field of longevity research but do so in a limited manner, focusing on a niche application rather than a transformative approach to aging.
Author of this paper? Send a correction.